-
Covishield dose interval under discussion: NTAGI working group chairman Dr N K Arora
The decision to increase the Covishield dose gap lay in the fundamental scientific reason regarding behaviour of adenovector vaccines.
-
Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to Centre
In early May, SII had communicated to the Centre that production of Covishield would be ramped up to 6.5 crore in June, seven crore in July and 10 cro
